Monthly Archives: November 2012

Visual Evoked Potential – New Technology Available at Total Eye Care

We have added a new service here at Total Eye Care. It is called the Visual Evoked Potential or VEP. Until recently this technology was only available to large institutions and teach hospitals. We are now able to provide this service for our patients at the Colleyville office.

What is the VEP?

The VEP, or Visual Evoked Potential, measures how well you visual system is working. Testing the integrity of your visual system is done by showing you a series of checkerboard patterns and then measuring the electrical activity between your eye and the visual cortex of your brain.

Your eye converts what you see into very low voltage electrical signals that travel along the optic nerve between your eye and the visual cortex. The computer inside the VEP compares the strength and speed of signal to a database of normal results and then the doctor uses that information to guide his or her diagnosis.

How is the VEP Done?

Two sticky pieces of tape are placed on your forehead and another on the back of your head. A patch is then placed over one eye and you look at a computer monitor that shows you the checkerboard pattern. When the testing is complete the process is reversed for the other eye. That’s all there is to it.

What Does the VEP Tell the Doctor?

The VEP evaluates how well the entire visual system is working. A visual field (peripheral vision test) gives the doctor similar information. In this way the VEP  helps the doctor diagnose and manage patients with glaucoma. The VEP is also used in the diagnosis and treatment of patients with amblyopia, multiple sclerosis, myasthenia gravis, optic atrophy, and concussion to name a few.

Total Eye Care Welcomes A New Eye Doctor

We are happy to announce that Total Eye Care is growing and Dr. Thuy Tran has joined our practice. Dr. Tran is an honor graduate of the University of Houston College of Optometry.  A native of Arlington, Dr. Tran will hold office hours at both the Colleyville and Keller locations.

Invisible Illness: Searching for a Cure

When Dr. Diana Driscoll was struck with a disabling invisible illness, Ehlers-Danlos syndrome with Dysautonomia, her quest for answers and compassion for other sufferers began.  As both a patient and a doctor (therapeutic optometrist), Dr. Diana has been working tirelessly researching a cure for those inflicted with these invisible illnesses such as CFS (Chronic Fatigue Syndrome or “M.E.”), Chronic Lyme Disease, Multiple Sclerosis, Fibromyalgia, Rheumatoid Arthritis, Ehlers-Danlos syndrome with Dysautonomia and Endometriosis.  Through collaboration, research and personal experimentation, she has found some answers to these debilitating diseases that have left many puzzled and without hope for so long.

In her desire to reach out to those who are suffering worldwide, Dr. Diana began the website www.Prettyill.com.  Here, you can view much of her research and gain support from a community of fellow patients.  While currently on professional disability, she is dedicating all of her available time and resources to the goal of providing hope to patients in discovering a cure.

Current clinical testing is being completely funded by Drs. Diana and Richard Driscoll.  This is not how science has traditionally worked, but this reflects their level of commitment to help individuals suffering from these chronic illnesses. Traditionally, applying for research grants and paying for large administrative costs not only slows research efforts, but can mean that the research is never completed. Drs. Rich and Diana Driscoll knew that it was time to instigate a change.  With great excitement, we are pleased to announce that Prettyill.com, run by Dr. Diana Driscoll, is currently partnering with Total Eye Care to begin preliminary clinical trial testing.

The initial patient testing consists of a blood test ($800 value), a questionnaire and ocular fundus photos ($125 value) and will be administered at NO COST to you, the patient. The deadline for participating in this clinical trial pretesting is November 31, 2012. If you or a loved one has been diagnosed with one or more of the diseases listed above, please contact us at .